Beijing Children’s Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma
- 1 June 2023
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (7) , 2393-2400
Abstract
Medulloblastoma (MB) is one of the most common malignant childhood brain tumors (WHO grade IV). Its high degree of malignancy leads to an unsatisfactory prognosis, requiring more precise and personalized treatment in the near future. Multi-omics and artificial intelligence have been playing a significant role in precise medical research, but their implementation needs a large amount of clinical information and biomaterials. For these reasons, it is urgent for current MB researchers to establish a large sample-size database of MB that contains complete clinical data and sufficient biomaterials such as blood, cerebrospinal fluid (CSF), cancer tissue, and urine. Unfortunately, there are few biobanks of pediatric central nervous system (CNS) tumors throughout the world for limited specimens, scarce funds, different standards collecting methods and et cl. Even though, China falls behind western countries in this area. The present research set up a standard workflow to construct the Beijing Children’s Hospital Medulloblastoma (BCH-MB) biobank. Clinical data from children with MB and for collecting and storing biomaterials, along with regular follow-up has been collected and recorded in this database. In the future, the BCH-MB biobank could make it possible to validate the promising biomarkers already identified, discover unrevealed MB biomarkers, develop novel therapies, and establish personalized prognostic models for children with MB upon the support of its sufficient data and biomaterials, laying the foundation for individualized therapies of children with MB.Keywords
All Related Versions
Funding Information
- Digestive Medical Coordinated Development Center of Beijing Hospitals Authority (XMLX202144)
This publication has 33 references indexed in Scilit:
- Intertumoral Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2017
- Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor StudyNeuro-Oncology, 2016
- AGORA, a data‐ and biobank for birth defects and childhood cancerBirth Defects Research Part A: Clinical and Molecular Teratology, 2016
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisThe Lancet Oncology, 2016
- Evidence of high mortality in long term survivors of childhood medulloblastomaJournal of Neuro-Oncology, 2015
- Cerebellum2011
- Familial Medulloblastoma: Case Report of One Family and Review of the LiteratureNeurosurgery, 2002
- Familial MedulloblastomaPediatric Hematology and Oncology, 1998
- Cancer risk and oxidative DNA damage in manJournal of Molecular Medicine, 1996
- Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996